1
Nov
2022

G.L. Pharma GmbH

Exhibitor at CPHI Frankfurt 2022 stand 41L41, Finished Dosage Formulations
About Us

G.L. Pharma specializes in the development, registration, manufacture and marketing of pharmaceutical specialties. We are a family owned company based in Austria with two state-of-the-art production facilities and over 900 dedicated employees. Through our partners and branch offices we are active in more than 50 countries worldwide. Looking back on a history of 70 years our core therapeutic areas are: Pain Management, Addiction Therapy, Epilepsy and Depressive Disorders.



  • AT
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Generics/Biosimilars Manufacturer
Licensee
Manufacturer/Innovator
Pharmaceutical company
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 41L41, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2022

  • Acetylsalicylic Acid

    Product Acetylsalicylic Acid

    gostro-resistant tablets
  • Valproic Acid/ Sodium Valproate

    Product Valproic Acid/ Sodium Valproate

    gastro-resistant soft capsule, syrup, oral solution, solution for injection, prolonged-release tablets 
  • Oxycodone

    Product Oxycodone

    film-coated tablets, prolonged release tablets, syrup, solution for injection or infusion
  • Morphine

    Product Morphine

    solution for injection
  • Buprenorphine

    Product Buprenorphine

    sublingual tablets